Allo-HSCT Vs. Auto-HSCT for PTCL Patients With PR After First-line Systemic Therapy : A Prospective, Multicenter, Cohort Study-(T-START-PR)

Name: Allo-HSCT Vs. Auto-HSCT for PTCL Patients With PR After First-line Systemic Therapy : A Prospective, Multicenter, Cohort Study-(T-START-PR)
Published: 2025
License: Public Domain

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · 2025

ClinicalTrials.gov · Datasets · License: Public Domain · 2025

Open Source ↗

peripheral t cell lymphoma, allogeneic hematopoietic stem cell transplantation, autologous hematopoietic stem cell transplantation, partial response, observational

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Allo-HSCT Vs. Auto-HSCT for PTCL Patients With PR After First-line Systemic Therapy : A Prospective, Multicenter, Cohort Study-(T-START-PR)

Related documents